LEVELS – A Whole New Level

Almost everything your doctor knows about you comes from a snapshot: a blood pressure reading, an annual lab, a handful of numbers meant to represent a constantly changing human body.

That's beginning to change. New sensors promise far more continuous health data, and AI may finally give us the ability to interpret it. But medicine has been through a data revolution before, and almost none of what people initially promised actually happened.

In the first episode of NextLevel, Mike Haney sits down with Dr. Robert Wachter, Chair of the Department of Medicine at UCSF and one of medicine's leading thinkers on technological change, to ask what healthcare's messy transition from paper to electronic records can teach us about the AI era.

Wachter explains why digitizing medicine didn't transform care on its own, why your doctor is already overwhelmed by data, and why simply sending them continuous feeds from your watch, ring, or future sensors would make the problem worse.

The missing piece is an intelligence layer: a system capable of deciding what matters, helping patients act when they can, and pulling clinicians in when they're actually needed.

They also explore how AI is changing the balance of knowledge between doctors and patients, the danger of trusting systems that are usually right, what healthcare can learn from airplane cockpits, and why collecting more health data may be much easier than figuring out what any of it means.

Free course: Improve your metabolic health
Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠

🎙️ About the Guest:
Dr. Robert M. Wachter is Professor and Chair of the Department of Medicine at the University of California, San Francisco. He’s also the author of six books, including the 2015 bestseller The Digital Doctor, which examined medicine's transition from paper to electronic health records, and 2026’s A Giant Leap: How AI Is Transforming Healthcare and What That Means for Our Future, his examination of generative AI's arrival in medicine.

📍What Dr.Robert Watcher & Mike Haney discussed:
0:00 — Dr. Wachter and medicine's technological revolutions
7:00 — How healthcare finally went digital
12:40 — Why digitizing healthcare didn't fix it
19:00 — AI is fixing problems computers created
29:40 — Does AI know more medicine than your doctor?
33:00 — The hidden danger of trusting computers
42:30 — What healthcare can learn from airplane cockpits
56:15 — Why medicine has to move beyond the office visit
58:20 — Healthcare's missing intelligence layer
1:04:20 — Why more health data isn't enough

🔗 Helpful Links:
Dr. Robert Wachter, UCSF Department of Medicine: https://medicine.ucsf.edu/people/robert-wachter
A Giant Leap: How AI Is Transforming Healthcare and What That Means for Our Future: https://bookshop.org/p/books/a-giant-leap-how-ai-is-transforming-healthcare-and-what-that-means-for-our-future-robert-wachter/e6a7ecb6556f9f02
The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine's Computer Age: https://bookshop.org/p/books/the-digital-doctor-hope-hype-and-harm-at-the-dawn-of-medicine-s-computer-age-robert-wachter/9187727
Pattern Recognition, Dr. Wachter's newsletter on AI and healthcare: https://robertwachter.substack.com/
Dr. Robert Wachter on LinkedIn: https://www.linkedin.com/in/robert-wachter-3102b963/

Watch the conversation: https://youtu.be/762DTOa7uTY
Find us on YouTube: ⁠https://youtube.com/levelshealth?sub_confirmation=1

👋 Who we are:
Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health.

Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

Healthcare is entering a new era.

AI is improving faster than our ability to measure the human body, while a new generation of sensors promises to change that. Together, they’ll reshape how we understand health, disease, and medicine itself.
NextLevel is our new series inside the podcast where we try to make sense of that future through conversations with the people building it.

Our first episode, featuring Dr. Bob Wachter, arrives this week.

Free course: Improve your metabolic health
Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠

👋 Who we are:
Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health.

You probably spend more time thinking about protein than friendships.
According to today's guest, you’ve got it backward.
In this episode of A Whole New Level, Mike Haney sits down with Dr. Julianne Holt-Lunstad, one of the world's leading researchers on social connection and health. She explains how data now unequivocally show that social isolation drives early mortality. And why simply not feeling lonely doesn't necessarily mean you're getting enough social connection, as well as why even weak connections matter a lot to a healthy social life.

Free course: Improve your metabolic health
Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠⁠https://levels.link/wnl⁠

🎙️ About the Guest:
Dr. Julianne Holt-Lunstad is a professor of psychology and neuroscience at Brigham Young University and one of the world's leading researchers on social connection and health. Her landmark meta-analyses involving millions of participants established social isolation and loneliness as independent risk factors for chronic disease and early mortality.

📍What Dr. Julianne Holt-Lunstad & Mike Haney discussed:
0:00 — Introduction
1:18 — How Dr. Holt-Lunstad began studying social connection and health
3:00 — Why relationships belong alongside diet, exercise, and sleep
4:10 — Social isolation vs. loneliness vs. living alone
11:45 — How researchers measure social connection and health outcomes
16:20 — The biological pathways linking isolation to disease
27:30 — How scientists study social connection without randomized trials
33:00 — Family, friends, weak ties, and what kinds of relationships matter|
37:00 — AI companions, loneliness, and whether technology can replace human connection
46:15 — Is there a minimum effective dose of friendship?
58:10 — Why Americans are participating in fewer clubs and community groups
1:03:20 — Why objective isolation predicts health better than loneliness
1:10:40 — Making friends as adults and overcoming the friction of connection

🔗 Helpful Links:
Dr. Julianne Holt-Lunstad
BYU Faculty Profile: https://psychology.byu.edu/directory/julianne-holt-lunstad
Social Connection in America Survey: https://www.socialconnectionguidelines.org/
U.S. Surgeon General Advisory on Social Connection: https://www.hhs.gov/sites/default/files/surgeon-general-social-connection-advisory.pdf
Key Research
Social Relationships and Mortality Risk: A Meta-analytic Review (Holt-Lunstad et al., 2010): https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000316
Loneliness and Social Isolation as Risk Factors for Mortality (Holt-Lunstad et al., 2015): https://perspectives.psychiatryonline.org/doi/10.1176/appi.ps.201500160
Our Epidemic of Loneliness and Isolation (U.S. Surgeon General, 2023): https://www.hhs.gov/sites/default/files/surgeon-general-social-connection-advisory.pdf
Bowling Alone (Robert Putnam): https://bowlingalone.com/

Watch the conversation: https://youtu.be/g6D2CIpB2n4
Find us on YouTube: https://youtube.com/levelshealth?sub_confirmation=1

👋 Who we are:
Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health.

Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

High cholesterol. Elevated ApoB. A positive CAC score. Now what?

Most people quickly find themselves trapped between two extremes: simplistic advice to “cut saturated fat” and online influencers insisting cholesterol doesn’t matter at all.
In this episode of A Whole New Level, Mike Haney sits down with clinical research scientist Dr. Kevin Maki to cut through the confusion.

Drawing on more than 35 years of cardiovascular research, Maki explains why heart disease risk is about much more than LDL cholesterol alone. He breaks down the roles of inflammation, blood sugar, family history, kidney function, and lipoproteins, while also making a clear case for something many people resist: LDL and ApoB still matter. A lot.

The evidence increasingly suggests that when it comes to atherosclerosis, lower for longer is better. That has important implications for diet, statins, and how early we should intervene.

Mike and Dr. Maki also tackle saturated fat, seed oils, red meat, industry-funded research, and how to separate evidence from online nutrition debates.

Free course: Improve your metabolic health

Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠https://levels.link/wnl⁠

🎙️ About the Guest:
Dr. Kevin Maki is founder and Chief Science Officer of Midwest Biomedical Research and an Adjunct Professor in the School of Public Health at Indiana University. A former president of the National Lipid Association, he has spent more than three decades designing and leading clinical trials focused on cardiovascular disease, diabetes, nutrition, and lipid management.

His research has included studies on cholesterol-lowering therapies, dietary patterns, red meat, seed oils, inflammation, and cardiometabolic risk reduction.

📍What Dr. Kevin Maki & Mike Haney discussed:
0:00 — Dr. Maki’s background in clinical research
4:30 — How industry-funded nutrition research actually works
15:00 — The Framingham Heart Study and the “Big Four” risk factors
20:00 — FLASH-GLICK: the ten factors that drive cardiovascular risk
26:00 — Why inflammation may be the next frontier in prevention
33:00 — LDL, ApoB, and the “lower for longer” principle
42:00 — Particle size, ApoB, and what advanced lipid testing adds
47:00 — Why everyone should know their Lp(a)
51:00 — Saturated fat, seed oils, and the “compared to what?” problem
62:00 — What the red meat evidence actually shows
72:00 — Statins, lifestyle, and LDL treatment goals
82:00 — Why earlier LDL lowering may provide the biggest benefit

🔗 Helpful Links:
Watch the conversation: https://youtu.be/l8QzuuTYxLI
Beef Consumption and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-analysis of Randomized Controlled Trials: https://pmc.ncbi.nlm.nih.gov/articles/PMC11621491/
Low-Density Lipoprotein Cholesterol Lowering and Risk of Major Adverse Cardiovascular Events in Primary Prevention Trials: A Meta-Analysis: https://www.sciencedirect.com/science/article/pii/S1933287426000395
PREDIMED Trial (Mediterranean Diet & Primary Prevention): https://www.nejm.org/doi/abs/10.1056/NEJMoa1200303
CORDIOPREV Trial: https://pubmed.ncbi.nlm.nih.gov/35525255/
The Framingham Heart Study: A Historical Perspective: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61752-3/abstract
Midwest Biomedical Research: https://midwestbiomedicalresearch.com/
National Lipid Association: https://www.lipid.org/

✅ Subscribe here on YouTube: https://youtube.com/levelshealth?sub_confirmation=1

👋 Who we are:
Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health.

Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.

What are GLP-1 drugs actually doing in the body, who are they for, and why might some people want to think twice before treating them like a six-month shortcut?
For years, obesity treatment focused largely on behavior: eat less, move more, stay motivated. Yet many people lost weight only to regain it. According to obesity medicine pioneer Dr. Robert Kushner, that wasn’t a failure of willpower. It was a failure to fully understand the biology driving weight regulation.
In this episode of A Whole New Level, Mike Haney sits down with Kushner, one of the leading figures in obesity medicine and a lead investigator on the landmark STEP trials, to discuss how GLP-1 medications are changing the field. He explains why these drugs may be the first treatments capable of helping patients “fight biology with biology,” why appetite regulation appears to work differently in different people, and why many patients describe a dramatic reduction in food noise after starting treatment.
But this conversation goes beyond how the drugs work. Kushner also addresses one of the biggest questions facing obesity medicine today: who should actually take these medications? He explains why obesity specialists evaluate far more than a number on the scale, why someone hoping to lose a modest amount of weight may want to think carefully before pursuing treatment, and why successful long-term health still requires changes that no medication can provide.
They also discuss obesity as a disease, the promise and limitations of telehealth prescribing, and why maintaining weight loss often requires something deeper than motivation: a shift in identity.

Free course: Improve your metabolic health
Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠https://levels.link/wnl⁠

🎙️ About the Guest:
Dr. Robert Kushner is Professor Emeritus of Medicine and Medical Education at Northwestern University Feinberg School of Medicine and one of the pioneers of modern obesity medicine. He is a past president of The Obesity Society, founder and former chair of the American Board of Obesity Medicine, and a lead investigator on the landmark STEP clinical trials that helped establish semaglutide as a treatment for obesity.

📍What Dr. Robert Kushner & Mike Haney discussed:
2:06 — Why obesity is more than willpower
4:34 — The benefits and drawbacks of calling obesity a disease6:27 — Clinical vs. preclinical obesity
17:36 — What obesity medicine misunderstood about weight regain
18:44 — “Fight biology with biology”
25:07 — Why weight maintenance is a different challenge than weight loss
26:49 — The identity shift that helps people keep weight off
27:52 — How GLP-1 drugs actually work
31:09 — Why some people experience constant food noise
34:09 — Why GLP-1s treat obesity but don’t cure it
42:17 — The STEP and SELECT trials
44:15 — Who should consider GLP-1 medications?
45:44 — Why obesity treatment is more than an online prescription
50:44 — What happens after you stop taking GLP-1s?

🔗 Helpful Links:
Watch the conversation: ⁠https://youtu.be/qdssFUAWVck
Dr. Robert Kushner: https://drrobertkushner.com/about/
Northwestern Faculty Profile: https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=11686
STEP Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
SELECT Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

👋 Who we are:
Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health.

Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.